- Current price
- Min Amount
- Earliest start
- 12 Feb 21:00
Invest in Exabeam
Exabeam is a leading provider of user and entity behaviour analytics. It applies machine learning algorithms to ensure cyber security and a cutting-edge data science and innovative Stateful User Tracking technology used to track and analyse user behaviour.
The company was founded in 2013 by security and enterprise IT veterans from Splunk, Imperva, and Sumo Logic. Exabeam is headquartered in San Mateo, California.
Since mid-2020, the company has been actively investing in the Exabeam Partner Program, which now includes more than 400 reseller, distributor, system integrator and consulting partners from all around the world. In addition, Exabeam maintains over 500 technology integrations with the leading IT and security companies, including CrowdStrike, Okta and Snowflake.
The global cyber security market was valued at $167 billion in 2020 and is expected to register a CAGR of 10.9% from 2021 to 2028.
While venture capital investment in cyber security has been rising fast over the past few years, this sector got an extra boost during the pandemic due to the unforeseen challenges created by the remote work conditions. According to the PitchBook data agency, venture funding in cyber security hit a record $10 billion in 2020 and as of May 2021 had already reached $8 billion.
Exabeam continuously monitors the sources of companies’ log data to determine “normal” activity so it can spotlight unusual activities and allocate a risk score. Exabeam was named a leader in the 2021 Gartner Magic Quadrant for Security Information and Event Management for the third consecutive time.
Exabeam faces strong competition in the security information and event management (SIEM) industry from a number of firms. Its closest rival Splunk has reached a market cap around $22 billion as of November 2021. This may have a negative effect on its long-term viability and valuation.
The company hit unicorn status with a $2.4 billion valuation in May 2021, when it raised $200 million in a Series F round led by the Owl Rock division of Blue Owl Capital. The previous round was held in May 2019 at a valuation of $800 million.
As of November 2021, Exabeam has raised a total of $390 million in 6 investment rounds from a number of top Silicon Valley VC firms, including Lightspeed Venture Partners (invested in Zscaler, Nutanix), Sapphire Ventures (invested in Livongo Health, Alteryx, Looker) and Norwest Venture Partners (invested in Health Catalyst, FireEye).
United Traders analysts are in continuous search for OTC offers studying financial reporting, companies’ businesses, their future plans, analyzing them as potential acquisition targets or estimating prospective multifold capitalization increase as well as considering risks that may hinder business growth. The best ideas are offered to our investors.
As part of our service for purchasing shares on the over-the-counter market (pre-IPO, OTC), for its traders and investors United Traders buys units in funds that own equity stakes in private companies. These funds make early-stage investments in private companies or acquire equity stakes from employees of such companies.
United Traders will have shares at its disposal after the IPO. The shares can be sold after the established 6-month Lock-up period. Alternatively, the shares can be hedged for the above period. Prior to the company going public United Traders look for exit options in the OTC market. If we find a great offer, we sell the shares.
After the Lock-up period is over, the investment in pre-IPO or OTC will be automatically closed, and generated profits are credited to your account less the applicable UT fees. We offer an opportunity for investors with over $100,000 invested in a specific idea to search for a counterpart in the OTC market individually and to take profits before the company goes public and thereby exiting the trade prior to the Lock-up period expiration.
Although it is prohibited to sell shares within the Lock-Up period, our traders find ways to take profits for our investors using various financial instruments: forwards, options, short selling trades, etc.
For an investor the above means that the pre-IPO or OTC investment may be exited after paying a part of its value, usually around 15% which is caused by highly-priced instruments used to close the position. To do so, you should press the respective button in your members area as soon as it becomes active.
The exiting process is similar to making a new investment. You submit a request, we execute it within 1 business day, and your investment is closed at the current exchange price.
3.5% of the share purchase amount. The fee is charged at confirmation of your investment bid.
0.5% of the share sell amount after the trade. The fee is charged at the investment exit.
20% of the profit gain. The fee is charged only if the trade is profitable at the time of exiting.
EARLY EXIT FEE
Usually a 15% fee is charged subject to the actual situation at the exchange. The fee is calculated individually for each investment.
WE ARE A RELIABLE PARTNER
Our risk managers will support you throughout the entire transaction life.
Venture investing is very risky as they involve new or growing companies, and multifold increase in capitalization is expected. We prioritize companies at the pre-IPO stage as they already demonstrate strong financial indicators and plan to go public soon. This approach allows limiting hyper-risks related to insolvency of new companies and substantially increasing profits as compared to investors who buy shares through a subscription just before the IPO.
LOW ENTRY THRESHOLD
To buy the OTC stocks, one would need millions of dollars. We gathered a pool of traders and investors allowing everyone interested to join similar transactions with as much as $10.
United Traders is experienced in minimizing risks but a future investor should be aware of all risk types:
- Illiquidity. There is a possibility that early exit from this investment will take more than 1 month.
- Asymmetric information. Management and current investors have access to more internal information about the company than other market participants.
- Time uncertainty. There is no information regarding next financing round or exit strategy timeframe (IPO or M&A).
- Share dilution. The issue of additional shares by a company may reduce the value of shares of existing investors.